| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Alpha melanocyte stimulating hormone and fragments: Components of the cutaneous defense and therapeutic potential
|
Luger, T.A.
|
|
2006
|
40 |
6 |
p. 424-425
2 p.
|
artikel
|
| 2 |
Analysis of ADNF-9 and NAP neuroprotection in human neurons: Relevance for Alzheimer disease and down syndrome therapies
|
Busciglio, J.
|
|
2006
|
40 |
6 |
p. 431-
1 p.
|
artikel
|
| 3 |
A new role for immunomodulatory neuropeptides during virus infections of the nervous system
|
Weihe, E.
|
|
2006
|
40 |
6 |
p. 437-
1 p.
|
artikel
|
| 4 |
A novel role for adrenomedullin as a pain-related peptide
|
Quirion, R.
|
|
2006
|
40 |
6 |
p. 437-438
2 p.
|
artikel
|
| 5 |
Anti-inflammatory mechanisms of NAP in neuroprotection
|
Pozo, D.
|
|
2006
|
40 |
6 |
p. 436-
1 p.
|
artikel
|
| 6 |
Central opioid and mesolimbic dopamine neurotransmission forms a nexus of neural pathways supporting motivation, palatability, drug addiction and obesity
|
Statnick, M.A.
|
|
2006
|
40 |
6 |
p. 428-
1 p.
|
artikel
|
| 7 |
Colocalization of CART peptide with prodynorphin and dopamine D1 receptors in the rat nucleus accumbens
|
Hubert, George W.
|
|
2006
|
40 |
6 |
p. 409-415
7 p.
|
artikel
|
| 8 |
Editorial
|
Gozes, Illana
|
|
2006
|
40 |
6 |
p. 417-
1 p.
|
artikel
|
| 9 |
Editorial Board
|
|
|
2006
|
40 |
6 |
p. i-
1 p.
|
artikel
|
| 10 |
Functions of the galanin peptide family in the skin
|
Kofler, B.
|
|
2006
|
40 |
6 |
p. 425-426
2 p.
|
artikel
|
| 11 |
Gene-expression modulation of TRH, its receptors, and inactivating enzyme, is brain-region specific and depends on the behavioural paradigm
|
Joseph-Bravo, P.
|
|
2006
|
40 |
6 |
p. 438-
1 p.
|
artikel
|
| 12 |
G-protein mediated signaling pathway in neuritogenesis and neuronal survival
|
Devi, L.A.
|
|
2006
|
40 |
6 |
p. 435-436
2 p.
|
artikel
|
| 13 |
Humanin and colivelin: Neuronal-death-suppressing peptides for Alzheimer’s disease
|
Matsuoka, M.
|
|
2006
|
40 |
6 |
p. 433-434
2 p.
|
artikel
|
| 14 |
Humanin, a potential peptide for Alzheimer’s disease therapy aiming at neuroprotection
|
Niikura, T.
|
|
2006
|
40 |
6 |
p. 434-
1 p.
|
artikel
|
| 15 |
Inhibition of amyloid-beta fibril formation and neurotoxicity by the cysteine protease inhibitor cystatin C
|
Levy, E.
|
|
2006
|
40 |
6 |
p. 427-428
2 p.
|
artikel
|
| 16 |
Investigating neuropeptides with DARC
|
Francesca Cordeiro, M.
|
|
2006
|
40 |
6 |
p. 434-435
2 p.
|
artikel
|
| 17 |
Meetings Calendar
|
|
|
2006
|
40 |
6 |
p. I-
1 p.
|
artikel
|
| 18 |
NAP ameliorates Alzheimer’s pathology in ad model mouse
|
Matsuoka, Y.
|
|
2006
|
40 |
6 |
p. 432-433
2 p.
|
artikel
|
| 19 |
Neurons containing tuberoinfundibular peptide of 39 residues are activated following male sexual behavior
|
Wang, Jing
|
|
2006
|
40 |
6 |
p. 403-408
6 p.
|
artikel
|
| 20 |
Neuropeptides and immune tolerance: Therapeutic applications on autoimmunity and transplantation
|
Delgado, M.
|
|
2006
|
40 |
6 |
p. 436-437
2 p.
|
artikel
|
| 21 |
Neuropeptide secretory granule biogenesis
|
Peng Loh, Y.
|
|
2006
|
40 |
6 |
p. 426-427
2 p.
|
artikel
|
| 22 |
Neuroprotective effect of ADNF and colivelin on ALS-relevant insults
|
Chiba, T.
|
|
2006
|
40 |
6 |
p. 433-
1 p.
|
artikel
|
| 23 |
New roles for neuropeptide and classical transmitter co-transmission in the skin
|
Weihe, E.
|
|
2006
|
40 |
6 |
p. 426-
1 p.
|
artikel
|
| 24 |
NO-cGMP mediated neuropeptides regulation in peripheral nerve injury
|
Thippeswamy, T.
|
|
2006
|
40 |
6 |
p. 431-
1 p.
|
artikel
|
| 25 |
Novel neuroprotective peptide colivelin: ADNF and humanin live together in harmony with the aim of curative therapies for both Alzheimer’s disease and ALS
|
Kita, Y.
|
|
2006
|
40 |
6 |
p. 434-
1 p.
|
artikel
|
| 26 |
Obesity in the carboxypeptidase E knockout mouse
|
Cawley, N.X.
|
|
2006
|
40 |
6 |
p. 429-
1 p.
|
artikel
|
| 27 |
PACAP and its role in gastrointestinal function
|
Pisegna, J.R.
|
|
2006
|
40 |
6 |
p. 424-
1 p.
|
artikel
|
| 28 |
P-2: Cortistatin, a new anti-inflammatory neuropeptide with therapeutic application on immune disorders
|
Gonzalez-Rey, E.
|
|
2006
|
40 |
6 |
p. 440-441
2 p.
|
artikel
|
| 29 |
Peptides derived from activity-dependent neurotrophic factor and activity-dependent neuroprotective protein protect the developing brain against the insult of prenatal alcohol exposure in C57 mice
|
Sari, Y.
|
|
2006
|
40 |
6 |
p. 432-
1 p.
|
artikel
|
| 30 |
P-1: Hemokinin activates rat septohippocampal cholinergic neurons via NK2 receptors
|
Alreja, M.
|
|
2006
|
40 |
6 |
p. 440-
1 p.
|
artikel
|
| 31 |
P-4: Hyperaemic effect of nociceptin/orphanin FQ in acutely inflamed rat joints is due to secondary release of sensory neuropeptides from capsaicin-sensitive nerves
|
McDougall, J.J.
|
|
2006
|
40 |
6 |
p. 441-442
2 p.
|
artikel
|
| 32 |
P-7: Increased endogenous ghrelin co-released by neuroendocrine tumors helps to overcome partial ghrelin resistance due to cancer cachexia
|
Wang, H.S.
|
|
2006
|
40 |
6 |
p. 442-443
2 p.
|
artikel
|
| 33 |
P-8: Involvement of proteoglycan-containing cells and/or the proteoglycan extracellular matrix in synaptic transmission
|
Garkun, Yu.S.
|
|
2006
|
40 |
6 |
p. 443-
1 p.
|
artikel
|
| 34 |
Post-golgi mechanism of trafficking of ACTH and BDNF vesicles to the release site
|
Park, J.
|
|
2006
|
40 |
6 |
p. 427-
1 p.
|
artikel
|
| 35 |
P-3: Peripheral sensitization of afferent nerves by VIP
|
McDougall, J.J.
|
|
2006
|
40 |
6 |
p. 441-
1 p.
|
artikel
|
| 36 |
Preclinical evaluation of melanin-concentrating hormone-1 receptor antagonist for the treatment of obesity and psychiatric disorders
|
Gehlert, D.R.
|
|
2006
|
40 |
6 |
p. 428-429
2 p.
|
artikel
|
| 37 |
Protecting against the outcome of taupathy: NAP – from concept to the clinic
|
Gozes, I.
|
|
2006
|
40 |
6 |
p. 429-430
2 p.
|
artikel
|
| 38 |
P-5: TCAP-1 administration in rats modulates the anxiogenic effects of CRF in three tests of anxiety
|
Rotzinger, S.
|
|
2006
|
40 |
6 |
p. 442-
1 p.
|
artikel
|
| 39 |
P-6: TRPV1 mediated neurogenic vasodilatation: Reactive oxygen species involvement
|
Starr, A.
|
|
2006
|
40 |
6 |
p. 442-
1 p.
|
artikel
|
| 40 |
P-9: Vasoactive intestinal peptide modulates plasmacytoid dendritic cell function by alteration of the immune phenotype and inhibition of IFNα secretion
|
Fabricius, D.
|
|
2006
|
40 |
6 |
p. 443-444
2 p.
|
artikel
|
| 41 |
Retinal growth hormone: Autocrine/paracrine cell survival mechanisms during retinal ganglion cell neurogenesis
|
Harvey, S.
|
|
2006
|
40 |
6 |
p. 435-
1 p.
|
artikel
|
| 42 |
Revealing the role of activity dependent neuroprotective protein during embryogenesis
|
Mandel, S.
|
|
2006
|
40 |
6 |
p. 430-
1 p.
|
artikel
|
| 43 |
Role of neuropeptides in appetite regulation and obesity – A review
|
Arora, Sarika
|
|
2006
|
40 |
6 |
p. 375-401
27 p.
|
artikel
|
| 44 |
Role of somatostatin receptor subtypes in antiepileptic actions of somatostatin
|
Tallent, M.K.
|
|
2006
|
40 |
6 |
p. 438-
1 p.
|
artikel
|
| 45 |
Structure and function of pyroglutamyl peptidase II, the TRH inactivating enzyme
|
Charli, J.-L.
|
|
2006
|
40 |
6 |
p. 439-
1 p.
|
artikel
|
| 46 |
Talking back: Target tissue instructions for peripheral neuron PACAP and VIP expression
|
May, V.
|
|
2006
|
40 |
6 |
p. 423-
1 p.
|
artikel
|
| 47 |
Thyrotropin-releasing hormone (TRH): Progress on its anticonvulsant mechanism and intranasal delivery to seizure foci
|
Kubek, M.J.
|
|
2006
|
40 |
6 |
p. 439-440
2 p.
|
artikel
|
| 48 |
TRPV1 – Emerging evidence for importance in cutaneous vascular and hyperalgesic components
|
Brain, S.
|
|
2006
|
40 |
6 |
p. 425-
1 p.
|
artikel
|
| 49 |
VIP: Design and synthesis of novel analogs and elucidating potential mechanisms affecting sexual function
|
Dangoor, D.
|
|
2006
|
40 |
6 |
p. 423-424
2 p.
|
artikel
|
| 50 |
VPAC1 receptors as molecular targets in breast cancer
|
Moody, T.W.
|
|
2006
|
40 |
6 |
p. 423-
1 p.
|
artikel
|
Tijdschrift beschrijving